IL6 and ovarian carcinoma: In ovarian cancer, interleukin-6 (IL-6) produced by the primary tumor stimulates the production of TPO by hepatic cells, the physiological source of TPO, which in turn induces megakaryocyte maturation and platelet production in the bone marrow (33), as a systemic effect and possibly prior to metastatic dissemination.